NCT05011851 An Open-Label Study of the Safety, Tolerability, and Pharmacokinetics of Oral NNZ-2591 in Angelman Syndrome Status COMPLETED Phase PHASE2
NCT04863794 A Study To Assess Distribution Of RO7248824 In The Central Nervous System Following Single Intrathecal Doses Of [89zr] Labeled RO7248824 In Healthy Male Participants Status COMPLETED Phase PHASE1
NCT04768803 Ghrelin in Patients With a Rare Disease Associated With Intellectual Disability, and Hyperphagia, and/or Overweight, and/or Obesity Status UNKNOWN Phase N/A
NCT04428281 A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7248824 in Participants With Angelman Syndrome (AS) Status COMPLETED Phase PHASE1
NCT04259281 A Study of the Safety and Tolerability of GTX-102 in Children With Angelman Syndrome Status COMPLETED Phase PHASE1/PHASE2
NCT03882918 An Open-Label Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of OV101 in Individuals With Angelman Syndrome Status TERMINATED Phase PHASE3
NCT03836300 Parent and Infant Inter(X)Action Intervention (PIXI) Status ENROLLING_BY_INVITATION Phase NA
NCT03235037 Clinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man Syndrome Status COMPLETED Phase NA
NCT02996305 A Study in Adults and Adolescents With Angelman Syndrome (STARS) Status COMPLETED Phase PHASE2
NCT02670694 Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW Status COMPLETED Phase N/A
NCT02056665 Study to Evaluate the Efficacy and Safety of Minocycline in Angelman Syndrome Status COMPLETED Phase PHASE2